BVF INC/IL - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 37 filers reported holding FATE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$1,268,000
-85.7%
391,386
-79.9%
0.20%
-86.9%
Q1 2017$8,851,000
-6.2%
1,945,245
-48.3%
1.50%
-20.6%
Q4 2016$9,436,0003,759,3981.90%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$200,277,00017.57%
Redmile Group, LLC 12,957,222$767,975,00013.39%
Copernicus Capital Management, LLC 12,000$711,0008.60%
Grosvenor Holdings, L.L.C. 1,037,256$61,478,0007.53%
DAFNA Capital Management LLC 344,360$20,410,0005.42%
Casdin Capital, LLC 3,400,000$201,518,0005.02%
Ally Bridge Group (NY) LLC 270,000$16,003,0004.70%
Darwin Global Management, Ltd. 353,250$20,937,0003.85%
Bellevue Group AG 3,238,036$191,918,0001.95%
Artal Group S.A. 1,450,000$85,942,0001.92%
View complete list of FATE THERAPEUTICS INC shareholders